These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38013157)

  • 41. The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions.
    Yee CS; Rachid R
    Curr Allergy Asthma Rep; 2016 Apr; 16(4):25. PubMed ID: 26922433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.
    Frischmeyer-Guerrerio PA; Masilamani M; Gu W; Brittain E; Wood R; Kim J; Nadeau K; Jarvinen KM; Grishin A; Lindblad R; Sampson HA
    J Allergy Clin Immunol; 2017 Oct; 140(4):1043-1053.e8. PubMed ID: 28414061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omalizumab in children with severe allergic disease: a case series.
    Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
    Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biologics in allergic rhinitis.
    Bayar Muluk N; Cingi C
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(5 Suppl):43-52. PubMed ID: 37869947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunotherapy in food allergy: towards new strategies.
    Sato S; Yanagida N; Ogura K; Asaumi T; Okada Y; Koike Y; Iikura K; Syukuya A; Ebisawa M
    Asian Pac J Allergy Immunol; 2014 Sep; 32(3):195-202. PubMed ID: 25268336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of omalizumab dose-related efficacy in oral immunotherapy: Evidence from a cohort of 181 patients.
    Azzano P; Paquin M; Langlois A; Morin C; Parizeault G; Lacombe-Barrios J; Samaan K; Graham F; Paradis L; Des Roches A; Bégin P
    J Allergy Clin Immunol; 2021 Jan; 147(1):233-243. PubMed ID: 32980425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A practical guide for implementing omalizumab therapy for food allergy.
    Casale TB; Fiocchi A; Greenhawt M
    J Allergy Clin Immunol; 2024 Jun; 153(6):1510-1517. PubMed ID: 38599291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biologic therapy for food allergy.
    Chen M; Zhang W; Lee L; Saxena J; Sindher S; Chinthrajah RS; Dant C; Nadeau K
    J Food Allergy; 2020 Sep; 2(1):86-90. PubMed ID: 39022154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Immunobiology and Treatment of Food Allergy.
    Barshow S; Tirumalasetty J; Sampath V; Zhou X; Seastedt H; Schuetz J; Nadeau K
    Annu Rev Immunol; 2024 Jun; 42(1):401-425. PubMed ID: 38360544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on omalizumab in allergen immunotherapy.
    Dantzer JA; Wood RA
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):559-568. PubMed ID: 34419967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Updates in food allergen immunotherapy.
    Szafron V; Rana R; Anvari S
    Curr Opin Pediatr; 2023 Dec; 35(6):680-685. PubMed ID: 37417834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant Therapies in Food Immunotherapy.
    Loh W; Tang M
    Immunol Allergy Clin North Am; 2018 Feb; 38(1):89-101. PubMed ID: 29132677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults.
    Mäntylä J; Thomander T; Hakulinen A; Kukkonen K; Palosuo K; Voutilainen H; Pelkonen A; Kauppi P
    Immun Inflamm Dis; 2018 Jun; 6(2):307-311. PubMed ID: 29542268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral immunotherapy for food allergy.
    Tang ML
    Curr Allergy Asthma Rep; 2009 Jan; 9(1):43-9. PubMed ID: 19063824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of food allergy oral immunotherapy in adults.
    Epstein-Rigbi N; Levy MB; Nachshon L; Koren Y; Katz Y; Goldberg MR; Elizur A
    Allergy; 2023 Mar; 78(3):803-811. PubMed ID: 36190349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New Approaches to Food Allergy Immunotherapy.
    Dantzer JA; Kim EH
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):546-552. PubMed ID: 37852441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of biological agents combined with oral immunotherapy (OIT) for food allergy: a protocol for a systematic review and meta-analysis.
    Honda A; Okada Y; Matsushita T; Hasegawa T; Ota E; Noma H; Imai T; Kwong J
    BMJ Open; 2024 Feb; 14(2):e075253. PubMed ID: 38326257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omalizumab for the Treatment of Multiple Food Allergies.
    Wood RA; Togias A; Sicherer SH; Shreffler WG; Kim EH; Jones SM; Leung DYM; Vickery BP; Bird JA; Spergel JM; Iqbal A; Olsson J; Ligueros-Saylan M; Uddin A; Calatroni A; Huckabee CM; Rogers NH; Yovetich N; Dantzer J; Mudd K; Wang J; Groetch M; Pyle D; Keet CA; Kulis M; Sindher SB; Long A; Scurlock AM; Lanser BJ; Lee T; Parrish C; Brown-Whitehorn T; Spergel AKR; Veri M; Hamrah SD; Brittain E; Poyser J; Wheatley LM; Chinthrajah RS
    N Engl J Med; 2024 Mar; 390(10):889-899. PubMed ID: 38407394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current options in the management of tree nut allergy: A systematic review and narrative synthesis.
    Pasioti M; Xepapadaki P; Mathioudakis AG; Lakoumentas J; Efstathiou E; Papadopoulos NG
    Pediatr Allergy Immunol; 2024 May; 35(5):e14132. PubMed ID: 38727626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut-allergic adolescents.
    van der Heiden M; Nopp A; Brandström J; Carvalho-Queiroz C; Nilsson C; Sverremark-Ekström E
    Scand J Immunol; 2021 Apr; 93(4):e13005. PubMed ID: 33244763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.